Sky Century Investment (SKYI) Assets Average (2013 - 2026)
Sky Century Investment (SKYI) posted quarterly Assets Average of $118579.5 for Q2 2026, up 25.95% year-over-year from $94147.5 in Q2 2025, and up 6.78% quarter-over-quarter from $111054.5 in Q1 2026.
Sky Century Investment (SKYI) Assets Average (2013 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported Assets Average for 4 consecutive years, with $118579.5 the latest figure, recorded in Q2 2026.
- In Q2 2026, Assets Average rose 25.95% year-over-year to $118579.5; the TTM figure through May 2026 stood at $118579.5 (up 25.95% YoY), while the FY2025 annual figure was $103563.0, up 115.98% from the prior year.
- Assets Average rose to $118579.5 in Q2 2026 per SKYI's latest filing, from $111054.5 in the prior quarter.
- Across five years, Assets Average topped out at $118579.5 in Q2 2026 and bottomed at $94147.5 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 5.97 Bn |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | 118,579.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 118,579.50 |
| Feb 28, 2026 | 111,054.50 |
| Nov 30, 2025 | 112,632.50 |
| Aug 31, 2025 | 118,089.50 |
| May 31, 2025 | 94,147.50 |
| Aug 31, 2014 | 515.00 |
| May 31, 2014 | 515.00 |
| Feb 28, 2014 | 3,040.00 |
| Nov 30, 2013 | 3,022.00 |
| Aug 31, 2013 | 316.50 |